enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. National Organization for Rare Disorders - Wikipedia

   en.wikipedia.org/wiki/National_Organization_for...

   The National Organization for Rare Disorders (NORD) is a nonprofit organization, based in Connecticut, [1] aiming to provide support for individuals with rare diseases by advocating and funding research, education, and networking among service providers. [2]

3. Columbus startup teaming with Eli Lilly to distribute weight ...

   www.aol.com/columbus-startup-teaming-eli-lilly...

   The new jobs at Gifthealth will have a payroll of $56.5 million and will include a mix of pharmacists, technicians, patient care representatives and other workers. The company currently has about ...

4. Pfizer, joining Lilly, enters the direct-to-consumer market ...

   www.aol.com/finance/pfizer-joining-lilly-enters...

   On Tuesday, Pfizer said it will enter the direct-to-consumer business, following the lead of a Big Pharma rival, Eli Lilly (), which launched a similar plan in January.The new website and patient ...

5. Eli Lilly and Company - Wikipedia

   en.wikipedia.org/wiki/Eli_Lilly_and_Company

   An assortment of Lilly's throat lozenges from a 1906 sales book Josiah K. Lilly Sr. (1861–1948), the company's second president Eli Lilly and Company's corporate headquarters in Indianapolis, c. 1919 Men and women workers preparing drug capsules at Eli Lilly and Company in 1919 Amaryllis belladonna cultivation at Eli Lilly and Company in 1919 ...

6. Solanezumab - Wikipedia

   en.wikipedia.org/wiki/Solanezumab

   Solanezumab (proposed INN, LY2062430 [1]) is a monoclonal antibody being investigated by Eli Lilly as a neuroprotector [2] for patients with Alzheimer's disease. [ 3 ] [ 4 ] The drug originally attracted extensive media coverage proclaiming it a breakthrough, but it has failed to show promise in Phase III trials.

7. Lilly weight loss drug prevents diabetes, company says - AOL

   www.aol.com/news/lilly-weight-loss-drug-prevents...

   In the SURMOUNT-1 trial, Lilly gave nearly 2,000 volunteers with pre-diabetes and obesity or overweight the drug at one of three different doses and 640 people a placebo and lifestyle counseling ...